Abbott’s TriCor With Statin Fails to Cut Diabetic Heart Risk - BusinessWeek
Links shared publicly online about this topic.
- 1,315total visits
Abbott’s TriCor With Statin Fails to Cut Diabetic Heart Risk - BusinessWeek
View full resource at businessweek.com
Tags: Heart, Heart Disease, Cholesterol, Cholesterol Medication, Heart Attack, Diabetes, Drug, TriCor
Most Recently Shared on March 14, 2010 at 4:10 pm By:
Bloomberg: Abbott’s TriCor With Statin Fails to Cut Diabetic Heart Risk. http://bit.ly/dtsc6Y
Abbott Labs To Pay $1.5B Over Anti-Seizure Drug Depakote : NPR
npr.org — “The company admitted that it marketed Depakote for unapproved uses, including treatment of schizophrenia, agitated dementia and autism. The case includes a criminal fine and forfeiture of $700 million and civil settlements with the federal government and states totaling $800 million.” View full resource at npr.org
Most Recently Shared on May 8, 2012 at 2:04 pm By:
Richard G. Lanzara Health Professional
Via @nprnews: Abbott Labs To Pay $1.5B Over Anti-Seizure Drug http://t.co/znWgC6CL #health #medicine #pharma
Abbott Laboratories to pay $1.6 billion over misbranding drug - CNN.com
edition.cnn.com — “Abbott Laboratories has pleaded guilty and agreed to pay $1.5 billion to resolve liability arising from unlawful promotion of Depakote.” View full resource at edition.cnn.com
Most Recently Shared on May 7, 2012 at 9:08 pm By:
Drugs and Devices OW OW Health
Abbott Laboratories to pay $1.5 billion over misbranding drug - CNN International: USA TODAYAbbott Laborat... http://t.co/2LFQ1f54 #drug
Abbott Buys AP214 Hormone From Action Pharma For $110 Million - WSJ.com
online.wsj.com — “Abbott Buys AP214 Hormone From Action Pharma For $110 Million - WSJ.com” View full resource at online.wsj.com
Most Recently Shared on May 3, 2012 at 7:54 pm By:
Ben Humphreys Doctor, Internist, Nephrologist, Research, and Physician
110M deal announced today: Abbot to license alphaMSH for Acute Kidney Injury in humans http://t.co/CD4C3paS
Testosterone Chases Viagra in Libido Race as Doctors Fret - Bloomberg
bloomberg.com — “Eli Lilly & Co. and Abbott Laboratories are offering help to the 13.8 million American men who have low levels of testosterone. Doctors warn that demand for the treatments could lead to overuse with deadly side effects.” View full resource at bloomberg.com
Most Recently Shared on May 2, 2012 at 1:09 pm By:
Testosterone products are hot--maybe too hot, per Bloomberg. #Lilly, #Abbott, et al expected to triple sales by 2017 http://t.co/DHXe56OJ
Rick Abbott reminisces about emergency medicine past
lifeinthefastlane.com — “Rick Abbott reminisces about emergency medicine past” View full resource at lifeinthefastlane.com
Most Recently Shared on May 2, 2012 at 12:02 am By:
Mike Cadogan Active Health Library, Doctor, Emergency Physician, and Physician
#LITFL update: I’m so old that… http://t.co/i2F30zWq
Abbott tries to throw up roadblock to Humira biosim - FierceBiotech
fiercebiotech.com — “Abbott tries to throw up roadblock to Humira biosim - FierceBiotech” View full resource at fiercebiotech.com
Most Recently Shared on May 1, 2012 at 4:37 pm By:
Abbott tries to throw up roadblock to Humira biosim http://t.co/SZdaeAiV $ABT #biosimilars #FDA #biotech #pharma
New St. Jude Medical and Abbott deal may be the model of the future
medcitynews.com — “Medical device marketing may look like this new partnership between St. Jude Medical and Abbott. Read more about this new device marketing partnership.” View full resource at medcitynews.com
Most Recently Shared on May 1, 2012 at 1:36 pm By:
Vascular Disease Man Medical Journal
New St. Jude Medical and Abbott deal may be the model of the future http://t.co/hwT9Fx1L
Want to cut health care costs? Start here. - The Washington Post
washingtonpost.com — “A tale of two drug companies.” View full resource at washingtonpost.com
Most Recently Shared on April 21, 2012 at 1:12 pm By:
Ben Miller PsyD, Doctor, and Psychologist
Want to cut #healthcare costs? Start here http://t.co/U77dEILa via @SarahKliff
HCV New Drug Research: EASL-Abbott Presents Positive Results from Interferon-Free Phase 2 "Co-Pilot" Study for the Treatment of Hepatitis C-ABT-450/r, plus ABT-333 and ribavirin
hepatitiscnewdrugs.blogspot.com — “HCV New Drug Research: EASL-Abbott Presents Positive Results from Interferon-Free Phase 2 "Co-Pilot" Study for the Treatment of Hepatitis C-ABT-450/r, plus ABT-333 and ribavirin” View full resource at hepatitiscnewdrugs.blogspot.com
Most Recently Shared on April 19, 2012 at 4:12 pm By:
Tina Banwart - HepatitisCNewDrugs Health Blog
EASL-Abbott Presents Positive Results from Interferon-Free Phase 2 "Co-Pilot" Study for the… http://t.co/es8fhWgM
Abbott Reports Double-Digit Ongoing Earnings-Per-Share Growth in First Quarter; Raises Full-Year... -- ABBOTT PARK, Ill., April 18, 2012 /PRNewswire/ --
prnewswire.com — “Abbott Reports Double-Digit Ongoing Earnings-Per-Share Growth in First Quarter; Raises Full-Year 2012 Outlook. -- First Quarter Ongoing EPS of $1.03, Up 13.2 Percent -- -- Raises Ongoing EPS Outlook for Full-Year 2012 -- -- On Track to Separate into Two Leading Health Care Companies by Year End --.” View full resource at prnewswire.com
Most Recently Shared on April 18, 2012 at 1:05 pm By:
Scott Strumello Patient Expert
Abbott Reports Double-Digit Ongoing Earnings-Per-Share Growth in Q1; Raises FY 2012 Outlook http://t.co/8e2yYufB via @PRNewswire
Ophthalmology
healio.com — “Ophthalmology” View full resource at healio.com
Most Recently Shared on April 17, 2012 at 1:29 pm By:
Have you seen our new website yet? Tell us what you think: http://t.co/xqIQqCra
Arch Intern Med -- Abstract: Avoidance of Generic Competition by Abbott Laboratories' Fenofibrate Franchise, April 9, 2012, Downing et al. 0 (2012): archinternmed.2012.187v1
archinte.ama-assn.org — “Archives of Internal Medicine, a bi-monthly professional medical journal published by the American Medical Association, publishes original peer-reviewed research articles on internal medicine topics” View full resource at archinte.ama-assn.org
Most Recently Shared on April 13, 2012 at 2:49 pm By:
ArchInternalMedicine Medical Journal
branded fenofibrate dominated the market for years through lawsuits and minor dose adjustments http://t.co/zkrASgtW #archinternmed
On the health beat: Hospital says McDonald's stays | StarTribune.com
startribune.com — “For more than 20 years, McDonald's has operated a popular fast-food outlet inside Abbott Northwestern Hospital in Minneapolis” View full resource at startribune.com
Most Recently Shared on April 13, 2012 at 2:44 pm By:
Would you like fries with that heart cath? Group asks U.S. hospitals to evict McDonald's. http://t.co/0SshCZWL #health #diet
Abbott's Humira OKed for new ulcerative colitis indication in EU « pharmaphorum forums
pharmaphorum.com — “Abbott's Humira OKed for new ulcerative colitis indication in EU « pharmaphorum forums” View full resource at pharmaphorum.com
Most Recently Shared on April 12, 2012 at 3:28 pm By:
eyeonfda Pharma and Health Lawyer
RT @pharmaphorum: Abbott's Humira OKed for new ulcerative colitis indication in EU: http://t.co/qOOiprPj #pharma #biotech
#IBS Abbott wins EU approval to use Humira in ulcerative colitis http://t.co/L1SYUXNK
snsanalytics.com — “#IBS Abbott wins EU approval to use Humira in ulcerative colitis http://t.co/L1SYUXNK” View full resource at snsanalytics.com
Most Recently Shared on April 12, 2012 at 1:35 am By:
#IBS Abbott wins EU approval to use Humira in ulcerative colitis http://t.co/L1SYUXNK
Advertisement
